Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy.
Carrato C, Alameda F, Esteve-Codina A, Pineda E, Arpí O, Martinez-García M, Mallo M, Gut M, Lopez-Martos R, Barco SD, Ribalta T, Capellades J, Puig J, Gallego O, Mesia C, Muñoz-Marmol AM, Archilla I, Arumí M, Blanc JM, Bellosillo B, Menendez S, Esteve A, Bagué S, Hernandez A, Craven-Bartle J, Fuentes R, Vidal N, Aldecoa I, Iglesia N, Balana C. Carrato C, et al. Among authors: arumi m. Clin Cancer Res. 2020 Dec 15;26(24):6600-6609. doi: 10.1158/1078-0432.CCR-20-2171. Epub 2020 Sep 30. Clin Cancer Res. 2020. PMID: 32998960
Prognostic value of stem cell markers in glioblastoma.
Alameda F, Velarde JM, Carrato C, Vidal N, Arumí M, Naranjo D, Martinez-Garcia M, Ribalta T, Balañá C. Alameda F, et al. Among authors: arumi m. Biomarkers. 2019 Nov;24(7):677-683. doi: 10.1080/1354750X.2019.1652345. Epub 2019 Sep 8. Biomarkers. 2019. PMID: 31496301
Safety and Efficacy of Crizotinib in Combination with Temozolomide and Radiotherapy in Patients with Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial.
Martínez-García M, Velasco G, Pineda E, Gil-Gil M, Alameda F, Capellades J, Martín-Soberón MC, López-Valero I, Tovar Ambel E, Foro P, Taus Á, Arumi M, Hernández-Laín A, Sepúlveda-Sánchez JM. Martínez-García M, et al. Among authors: arumi m. Cancers (Basel). 2022 May 12;14(10):2393. doi: 10.3390/cancers14102393. Cancers (Basel). 2022. PMID: 35625997 Free PMC article.
Are ER+PR+ and ER+PR- breast tumors genetically different? A CGH array study.
Carracedo A, Salido M, Corominas JM, Rojo F, Ferreira BI, Suela J, Tusquets I, Corzo C, Segura M, Espinet B, Cigudosa JC, Arumi M, Albanell J, Serrano S, Solé F. Carracedo A, et al. Among authors: arumi m. Cancer Genet. 2012 Apr;205(4):138-46. doi: 10.1016/j.cancergen.2012.01.001. Cancer Genet. 2012. PMID: 22559974
FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors.
Carracedo A, Egervari K, Salido M, Rojo F, Corominas JM, Arumi M, Corzo C, Tusquets I, Espinet B, Rovira A, Albanell J, Szollosi Z, Serrano S, Solé F. Carracedo A, et al. Among authors: arumi m. Breast Cancer Res. 2009;11(2):402. doi: 10.1186/bcr2239. Epub 2009 Apr 21. Breast Cancer Res. 2009. PMID: 19439036 Free PMC article. No abstract available.
Chronic pruritic warty papules on the buttocks.
Alcalá R, March Á, Arumí M, Pujol RM. Alcalá R, et al. Among authors: arumi m. Int J Dermatol. 2018 Jun;57(6):661-663. doi: 10.1111/ijd.13915. Epub 2018 Jan 22. Int J Dermatol. 2018. PMID: 29355937 No abstract available.
Renal malakoplakia: report of a case with multifocal involvement.
Lloreta J, Cañas MA, Munné A, Arumí M, Bielsa O, Gelabert A, Serrano S. Lloreta J, et al. Among authors: arumi m. Ultrastruct Pathol. 1997 Nov-Dec;21(6):575-85. doi: 10.3109/01913129709016374. Ultrastruct Pathol. 1997. PMID: 9355240
Biallelic alterations in PLXND1 cause common arterial trunk and other cardiac malformations in humans.
Guimier A, de Pontual L, Braddock SR, Torti E, Pérez-Jurado LA, Muñoz-Cabello P, Arumí M, Monaghan KG, Lee H, Wang LK, Pluym ID, Lynch SA, Stals K, Ellard S, Muller C, Houyel L, Cohen L, Lyonnet S, Bajolle F, Amiel J, Gordon CT. Guimier A, et al. Among authors: arumi m. Hum Mol Genet. 2023 Jan 13;32(3):353-356. doi: 10.1093/hmg/ddac084. Hum Mol Genet. 2023. PMID: 35396997 No abstract available.
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response.
Brasó-Maristany F, Ferrero-Cafiero JM, Falato C, Martínez-Sáez O, Cejalvo JM, Margelí M, Tolosa P, Salvador-Bofill FJ, Cruz J, González-Farré B, Sanfeliu E, Òdena A, Serra V, Pardo F, Luna Barrera AM, Arumi M, Guerra JA, Villacampa G, Sánchez-Bayona R, Ciruelos E, Espinosa-Bravo M, Izarzugaza Y, Galván P, Matito J, Pernas S, Vidal M, Santhanagopal A, Sellami D, Esker S, Fan PD, Suto F, Vivancos A, Pascual T, Prat A, Oliveira M. Brasó-Maristany F, et al. Among authors: arumi m. Nat Commun. 2024 Jul 11;15(1):5826. doi: 10.1038/s41467-024-50056-y. Nat Commun. 2024. PMID: 38992028 Free PMC article.
24 results